Showing results (21-30 of 377) with videos related to

Sort By:
Pageof 38
Therapeutic Advances in Hematology|February 26, 2019
Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemiaNicholas J Short, Hagop Kantarjian, Farhad Ravandi, et al.
Leukemia|May 6, 2021
T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developmentsNaval Daver, Ahmad S Alotaibi, Veit Bücklein, et al.
The Oncologist|August 26, 2015
Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic ImplicationsAziz Nazha, Joseph D Khoury, Raajit K Rampal, et al.
Frontiers in Oncology|November 30, 2020
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future DirectionsBachar Samra, Marina Konopleva, Alessandro Isidori, et al.
Statistics in Medicine|June 8, 2021
A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rulesJian Wang, Junsheng Ma, Chunyan Cai, et al.
Blood Cancer Discovery|January 11, 2022
Checkpoint Blockade + Chemotherapy: the Right Combination for AML?Spencer C Wei, James J Mancuso, Naval Daver, et al.
Leukemia|January 18, 2019
Targeting FLT3 mutations in AML: review of current knowledge and evidenceNaval Daver, Richard F Schlenk, Nigel H Russell, et al.
Leukemia & Lymphoma|September 25, 2019
CPX-351 (vyxeos) in AMLMansour Alfayez, Hagop Kantarjian, Tapan Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
Diagnostic Challenges of Hemophagocytic LymphohistiocytosisZaher K Otrock, Naval Daver, Hagop M Kantarjian, et al.
Cancer Management and Research|October 22, 2019
Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient SelectionHussein A Abbas, Mansour Alfayez, Tapan Kadia, et al.
Pageof 38